MINOCYCLINE HYDROCHLORIDE by Novartis is extended-release tablets for the treatment of acne is unknown. Approved for only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age, older. First approved in 2009.
Drug data last refreshed 18h ago
extended-release tablets for the treatment of acne is unknown.
Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel
Worked on MINOCYCLINE HYDROCHLORIDE at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.